N80 F52
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • (Suspected) diagnosis of endometriosis with a report • Sexual distress due to sexual dysfunction
Exclusion criteria
Exclusion criteria: • Major depression • Severe anxiety disorder • Suicidal ideation in the past 5 years • Current post-traumatic stress disorder • Substance dependence in the past 2 years • Acute psychosis • Current pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim is to investigate feasibility using a mixed methods approach in terms of acceptability, adherence, and safety. Exploratory changes will be measured on the following scales: • Female Sexual Distress Scale-Desire/Arousal/Orgasm (FSDS) (t1, t2, t3, t4) • Female Sexual Function Index (FSFI-d) (t1, t2, t3, t4) • Sexual Self-Esteem Inventory (SSEI-d) (t1, t2, t3, t4) • Inventory of Sexuality Functions (3D) (t1, t2, t3, t4) • Questionnaire on Resources in Sexuality and Partnership (RSP) (t1, t2, t3, t4) • Partnership Questionnaire (PFB) (t1, t3, t4) • Patient-Reported Outcome Measurement Information System (PROMIS-29) (t1, t2, t3, t4) • EUROHIS-QOL (t1, t3, t4) • Fear of Sexuality Questionnaire (FSQ) (t1, t2, t3, t4) • Vaginal Penetration Cognition Questionnaire (VPCQ) (t1, t2, t3, t4) • Central Sensitization Inventory German Version (CSI-GE) (t1, t2, t3, t4) • International Consultation on Incontinence Questionnaire Female Lower Urinary Tract Symptoms Modules (ICIQ-FLUTS) (t1, t2, t3, t4) • Perceived Stress Scale (PSS-10) (t1, t2, t3, t4) • Beck Depression Inventory (BDI-II) (t1, t3) • Generalized Anxiety Disorder Questionnaire (GAD-7) (t1, t3) • Brief Symptom Inventory (BSI) (t1, t3) • Perceived Services in the Healthcare System (t1, t3, t4) Additional for Intervention Group: • Satisfaction with the intervention on a visual analog scale (1-10) (t3) • Client Satisfaction Questionnaire with Internet Interventions (CSWIQ-8) (t2, t3) • mHealth App Usability Questionnaire (G-MAUQ) (t2, t3) • Inventory for the Assessment of Negative Effects in Psychotherapy (INEP) (t3, t4) • Serious Adverse Events (SAE) (t1-t3) • Dropout (t1-t4) | — |
Countries
Austria, Germany, Switzerland
Contacts
Institut für Sexualwissenschaft und Sexualmedizin